fostemsavir tromethamine
fostemsavir tromethamine is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Rukobia. Available dosage form: tablet, film coated, extended release.
Drug Details
- Generic Name
- fostemsavir tromethamine
- Brand Names
- Rukobia
- Application Number
- NDA212950
- Sponsor
- ViiV Healthcare Company
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- FOSTEMSAVIR TROMETHAMINE
Indications and Usage
1 INDICATIONS AND USAGE RUKOBIA, in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations [see Clinical Studies ( 14 )]. RUKOBIA, a human immunodeficiency virus type 1 (HIV-1) gp120-directed attachment inhibitor, in combination with other antiretroviral(s), is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations. ( 1 , 12.4 )